US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.89
▼-1.02%
TSLA
$378.69
▲+2.18%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.89
▼-1.02%
TSLA
$378.69
▲+2.18%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Arcellx, Inc. - Common Stock
(NQ:
ACLX
)
115.07
UNCHANGED
Last Price
Updated: 4:15 PM EDT, Apr 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcellx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Opening Day: Arcellx Raises $124M In Wall Street Debut
↗
February 05, 2022
Cell therapy biotech Arcellx made its public debut on Friday, raising $124 million to bankroll its multiple myeloma CAR-T study.
Via
Talk Markets
CAR-T Player Arcellx Raises $123M Via Initial Public Offering, Opens Trading At $19
↗
February 04, 2022
CAR-T company Arcellx Inc (NASDAQ: ACLX) priced its IPO at
Via
Benzinga
Arcellx, Inc To Start Trading Tomorrow
↗
February 03, 2022
ARCELLX, INC (NASDAQ:ACLX) IPO will take place February, 04 on the NASDAQ exchange under the ticker ACLX. The company is offering shares at an expected price between $15.00 and $...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >